Posted in

Time, two Italians in the top 100 in the health field. That’s who I am

Time, two Italians in the top 100 in the health field. That’s who I am

Two Italians Acknowledged in TIME Journal’s 2025 TIME100 Well being Listing

Rome, Might 12, 2025 – TIME Journal has unveiled its second annual TIME100 Well being record, spotlighting the 100 most influential people shaping the way forward for world well being. Amongst this prestigious cohort are two Italians: Francesco Rubino, featured within the “Leaders” class, and Lorenzo Guglielmetti, acknowledged within the “Catalysts” class. Their inclusion underscores Italy’s rising impression in addressing vital well being challenges worldwide.

Francesco Rubino: Pioneering Surgical Options

Francesco Rubino, a professor at King’s School London, has earned his place on the TIME100 Well being record for his groundbreaking work in metabolic surgical procedure. His analysis has redefined the understanding of surgical interventions for weight problems and kind 2 diabetes, demonstrating that procedures like gastric bypass can immediately tackle metabolic ailments past mere weight reduction. Rubino’s advocacy for integrating surgical procedure into normal diabetes care has influenced world well being insurance policies and scientific practices, providing new hope to tens of millions. His recognition as a “Chief” displays his function in driving systemic change in how continual ailments are managed.

Lorenzo Guglielmetti: Advancing Tuberculosis Therapy

Lorenzo Guglielmetti, co-principal investigator of the Finish TB undertaking, has been honored as a “Catalyst” for his transformative contributions to tuberculosis (TB) analysis. In 2025, Guglielmetti revealed a landmark examine within the New England Journal of Drugs, detailing three new oral drug therapies for rifampicin-resistant TB. These therapies have confirmed efficient, lowering therapy length and minimizing uncomfortable side effects in comparison with conventional strategies. Performed in collaboration with Médecins Sans Frontières, Companions In Well being, and Interactive Analysis and Growth, his work addresses a “forgotten” illness that impacts tens of millions, significantly in low-resource settings.

Guglielmetti, who graduated from the College of Verona and honed his experience in epidemiology and world well being on the Sorbonne in Paris, expressed shock and pleasure on the recognition. “This honor is shared with my colleagues who’ve labored tirelessly to fight TB,” he informed ANSA. He additionally introduced his return to Italy in June 2025 to proceed his analysis on the IRCCS Sacro Cuore in Negrar, viewing it as a “nice problem and alternative” to advance world well being from his house nation.

A Milestone for Italian Well being Innovation

The inclusion of Rubino and Guglielmetti within the TIME100 Well being record highlights Italy’s contributions to medical innovation amid a posh world well being panorama. TIME editors famous that 2025 marks an unprecedented yr in world well being, citing upheavals just like the U.S. withdrawal from the World Well being Group and important coverage shifts. Towards this backdrop, the work of Rubino and Guglielmetti stands out for its tangible impression on sufferers’ lives.

The 2025 TIME100 Well being record, curated by TIME’s well being correspondents and editors with steering from Dr. David Agus and Arianna Huffington, additionally options luminaries like WHO Director-Common Tedros Adhanom Ghebreyesus, U.S. Well being Secretary Robert F. Kennedy Jr., and philanthropist Melinda French Gates. The total record is obtainable within the Might 26, 2025, difficulty of TIME and on-line at time.com/time100health.

Trying Forward

Each Italians are poised to proceed their influential work. Rubino’s analysis is anticipated to additional combine surgical options into mainstream healthcare, whereas Guglielmetti’s return to Italy indicators a brand new chapter in TB analysis. Their recognition not solely celebrates their achievements but additionally amplifies the significance of addressing continual and infectious ailments on a worldwide scale.

Sources: TIME Journal, ANSA, RIFday